ResultsIQ › Latest results › SG Mart Limited
SG Mart Limited Q4 FY25 earnings call summary
NSE: SGMART · BSE: 512329
Earnings call of 19 May 2025, summarised by AI from the filing.
SG Mart reported FY25 revenue of ₹5,800 cr and EBITDA of ₹103 cr, guiding to ₹200 cr EBITDA in FY26 and ₹400 cr in FY27.
Key takeaways
- FY25 results Revenue ₹5,800 cr, EBITDA ₹103 cr and net profit ₹103 cr in first full year of operations.
- Growth drivers Service centres, B2B trading, solar structures and distribution verticals all expanding.
- Key risk Non-availability of steel is the only risk management sees.
SG Mart Limited Q1 FY27 results
As filed: Revenue ₹1,156 cr, EBITDA ₹41.2 cr, PAT ₹33.7 cr, EBITDA margin 3.6%.
Not scored. No result for the same quarter last year.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹1,588 cr, EBITDA ₹44.1 cr, PAT ₹34.0 cr, EBITDA margin 2.8%. Not scored. No result for the same quarter last year. Share price after the results: −0.1% in 30 days (Nifty 500: −1.0%).
- Q3 FY26: Revenue ₹1,407 cr, EBITDA ₹8.0 cr, PAT ₹6.7 cr, EBITDA margin 0.6%. Not scored. No result for the same quarter last year. Share price after the results: +39.3% in 28 days (Nifty 500: +1.7%).
- Q2 FY26: Revenue ₹1,508 cr, EBITDA ₹15.0 cr, PAT ₹17.0 cr, EBITDA margin 1.0%. Not scored. No result for the same quarter last year. Share price after the results: −5.2% in 29 days (Nifty 500: −0.1%).
Past price moves after results do not indicate future moves. Not a recommendation.
SG Mart Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (20 Jul 2026), Results deck (20 Jul 2026)
- Q4 FY26: Earnings call (4 May 2026), Results deck (4 May 2026)
- Q3 FY26: Earnings call (23 Jan 2026), Results deck (23 Jan 2026)
- Q2 FY26: Earnings call (31 Oct 2025), Results deck (30 Oct 2025)
- Q1 FY26: Earnings call (28 Jul 2025), Results deck (25 Jul 2025)
- Q4 FY25: Earnings call (19 May 2025), Results deck (16 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.